Translational Development Acquisition Corp.
NASDAQ:TDACShell Companies
-$0.01 today
- Market cap
- $267.99M
- Beta
- 0.01
- P/E (TTM)
- 29.8
- EPS (TTM)
- $0.36
Volume 0.47M
Average 0.10M
TDAC Total Equity
Shareholders' claim on the company's assets after all liabilities: total assets minus total liabilities.
Translational Development Acquisition Corp.NASDAQ: TDAC
Total Equity · Q1 FY2026 · quarter ended Mar 2026
Total equity rises 3.6% from a year ago
Total equity stood at $176.45M at the end of Q1 FY2026, up 3.6% from a year earlier and up 0.8% from the prior quarter.
Context
- Total equity amounted to 96.2% of total assets at the end of Q1 FY2026, down 0.2 pp from a year earlier.
- Total equity increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether total equity keeps rising in the next quarterly balance sheet after a +3.6% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Equity history
USD · from the balance sheet
- Latest · FY2025
- 175.12M USD
- Year-over-year change
- +3.8%
| Period | Period end | Total Equity | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 175.12M | +3.8% |
| FY2024 | 2024-12-31 | 168.75M | +33341.4% |
| FY2023 | 2023-12-31 | (507.66K) | -2196.3% |
| FY2022 | 2022-12-31 | (22.11K) | — |
Total Equity vs competitors
How TDAC compares with its peers on the latest reported figures
- TDAC's Mar 2026 total equity of $176.45M is the 4th highest of the 7 companies compared; the peer median is $177.12M.
- Its year-over-year change of +3.6% is the 4th highest of 6, against a peer median of +3.7%.
- Total equity amounts to 96.2% of total assets for TDAC, versus a peer median of 94.1%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $228.48M | +270622.8% | +14.6% | 95.3% | |
| Mar 2026 | $189.57M | +6860.4% | +3047.7% | 90.4% | |
NTWONewbury Street II Acquisition Corp | Mar 2026 | $177.95M | +3.7% | — | 96.7% |
| Mar 2026 | $176.45M | +3.6% | — | 96.2% | |
| Mar 2026 | $176.3M | +2.7% | -19.7% | 94.9% | |
MACIMelar Acquisition Corp. I | Mar 2026 | $165.2M | +3.0% | — | 93.4% |
| Jun 2025 | -$22.55K | — | — | 5.4% | |
| Peer median (excluding TDAC) | $177.12M | +3.7% | +14.6% | 94.1% | |
Competitors are the stored peer set for TDAC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Translational Development Acquisition Corp.
NASDAQ:TDAC
Intrinsic Alpha fair value
Locked
Current Price
$10.88
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.